AUSTIN DITTRICH: Open Payments
NPI 1437799590 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 14 payments from 5 companies in 2025. Trend: 2023 $337 · 2024 $1,907 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $141 |
| Medtronic, Inc. | 2 | $79 |
| Janssen Biotech, Inc. | 1 | $69 |
| Olympus America Inc. | 2 | $56 |
| Boston Scientific Corporation | 1 | $19 |
Products named: GEMTESA, RYBREVANT, iTIND System, EMPRINT, SpaceOAR VUE System - 10mL.
Industry payments across TX — which companies pay providers there.
